Rival puts AstraZeneca under pressure
Pharmaceuticals giant AstraZeneca saw its share price fall 2% today after a rival applied to make a copycat version of its key ulcer treatment.
Astra said Ranbaxy Laboratories, based in India, had filed an application to the US authorities to create a rival to Nexium, used to treat stomach ulcers and heartburn.